Get Your Personalized Supplement StackSupplement Stack Quiz

Silk Tree Bark Extract

Also known as: Silk Tree Bark Extract, Persian Silk Tree, Albizia, Constantinople Acacia, Constantinople Mimosa, Night Sleeper, Albizia julibrissin

Overview

Albizia julibrissin, commonly known as Silk Tree Bark Extract, is derived from the bark of the Albizia julibrissin tree, native to East and South Asia. This botanical extract is typically obtained through aqueous maceration and filtration of the bark. It is primarily used in skin care for its antioxidant, anti-glycation, firming, and brightening effects, helping to improve skin radiance and reduce signs of fatigue and dark circles. Additionally, it has been investigated for its neuropsychological properties, particularly its potential antidepressant activity. The extract contains bioactive phytochemicals such as julibrosides, triterpenoid saponins, flavonoids, and lignan glycosides, which are believed to contribute to its beneficial effects. While traditional use and some preclinical and small-scale clinical studies exist, the research on Albizia julibrissin bark extract is still emerging, with a need for more high-quality randomized controlled trials and systematic reviews to fully establish its efficacy and safety.

Benefits

Silk Tree Bark Extract offers several potential benefits, primarily in skin health and neuropsychological well-being. For skin, it exhibits strong antioxidant and anti-glycation properties, which are crucial for improving skin radiance, firmness, and reducing visible signs of skin fatigue and dark circles. This benefit is supported by preliminary studies and its use in topical formulations, with improvements observed over weeks of consistent application. The strength of evidence for skin benefits is moderate, largely based on the known mechanisms of its active compounds and some product-specific claims. In the neuropsychological domain, extracts and isolated lignan glycosides from Albizia julibrissin have demonstrated antidepressant-like effects in animal models. These effects are linked to the noncompetitive inhibition of the serotonin transporter (SERT), suggesting potential mood-enhancing benefits. While promising, the evidence for neuropsychological effects is primarily preclinical, requiring further clinical validation. Secondary effects, such as potential antimicrobial and UV-protective properties, have been observed in related bark extracts, but direct evidence for Albizia julibrissin bark is limited. Individuals with dull or fatigued skin may benefit most from its topical application, while those with stress-related mood disorders might find its neuropsychological effects relevant, though clinical application is not yet established.

How it works

The mechanism of action for Silk Tree Bark Extract involves multiple biological pathways. Its antioxidant activity is primarily attributed to free radical scavenging and the inhibition of pro-inflammatory transcription factors like NF-κB, which helps protect cells from oxidative damage and reduce inflammation. The anti-glycation effects contribute to maintaining skin elasticity and preventing the formation of advanced glycation end products (AGEs), which are implicated in skin aging. For its neuropsychological effects, the extract's active compounds, particularly lignan glycosides, have been shown to noncompetitively inhibit the serotonin transporter (SERT). This inhibition increases serotonin availability in the brain, contributing to antidepressant-like effects. Additionally, there is some evidence of weak inhibition of dopamine and norepinephrine transporters, further modulating monoamine levels. The flavonoids and saponins present in the extract also contribute to its overall antioxidant and anti-glycation properties.

Side effects

Overall, Silk Tree Bark Extract is generally considered safe for topical and oral use based on traditional applications and limited clinical data. However, robust safety data from large-scale clinical trials are lacking. No significant adverse effects have been widely reported in the reviewed literature. A potential concern arises from its interaction with dopamine transporters, which could theoretically lead to addictive side effects, although the clinical relevance of this in humans is currently unknown and requires further investigation. Due to its demonstrated ability to inhibit serotonin, dopamine, and norepinephrine transporters, there is a theoretical risk of drug interactions with other central nervous system (CNS)-active medications, particularly antidepressants (e.g., SSRIs, SNRIs, MAOIs) or dopaminergic drugs. Individuals taking such medications should exercise caution and consult a healthcare professional before using Albizia julibrissin. Contraindications are not well-defined, but caution is advised for patients on serotonergic or dopaminergic medications. The safety of Silk Tree Bark Extract during pregnancy, lactation, and in children has not been established, and its use in these special populations is not recommended without medical supervision.

Dosage

Specific dosage guidelines for Silk Tree Bark Extract, particularly for oral use, are not well-established due to a lack of robust clinical data. For topical applications, a concentration of approximately 3% aqueous extract is commonly recommended in cosmetic formulations for skin benefits. This concentration is typically applied daily. For oral use, optimal dosages are unknown, as most research on neuropsychological effects has involved isolated compounds rather than whole extracts, primarily in animal studies. Therefore, a minimum effective dose and a maximum safe dose for oral consumption in humans have not been defined. The timing of oral administration is also not standardized and requires further study. Aqueous extracts are the most common form, and their water solubility facilitates topical absorption. Data on the oral bioavailability of the extract in humans are currently lacking. No specific cofactors are identified as necessary for its efficacy.

FAQs

Is Silk Tree Bark Extract safe for daily use?

Limited data suggest it is safe for daily topical use in cosmetic products. However, its oral safety requires more extensive research before daily oral use can be broadly recommended.

Can it replace antidepressants?

No, it cannot. While preclinical studies show antidepressant-like activity, the clinical evidence is insufficient to support its use as a replacement for prescribed antidepressants.

How soon will skin benefits appear?

Improvements in skin radiance, firmness, and reduction of fatigue signs may be noticed after several weeks of consistent daily topical application.

Are there risks of addiction?

Potential effects on dopamine transporters raise theoretical concerns about addiction, but the clinical relevance of this risk in humans is currently unknown and needs further investigation.

Research Sources

https://us.typology.com/library/fiche-didentite-extrait-aqueux-darbre-a-soie – This source from Typology describes the identity and benefits profile of aqueous Silk Tree Bark Extract, highlighting its antioxidant, anti-glycation, and skin-firming effects. It recommends a 3% aqueous extract concentration for topical use in cosmetic products, noting its role in improving skin radiance and reducing signs of fatigue. The information is presented from a cosmetic product perspective rather than a clinical trial.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9854852/ – This review by Gunnarsdottir et al. (2023) discusses the antioxidative and immunomodulatory properties of various tree bark extracts. While it notes the potential for NF-κB inhibition and skin barrier improvements observed in clinical trials with other bark extracts, it explicitly states that direct evidence for Albizia julibrissin is limited, though mechanistically plausible given its phytochemical composition.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10230641/ – Huang et al. (2023) demonstrated in vitro and animal model antidepressant effects of lignan glycosides isolated from Albizia julibrissin. The study found noncompetitive inhibition of the serotonin transporter (SERT) and weak inhibition of dopamine and norepinephrine transporters, suggesting novel mechanisms for its mood-enhancing properties but also raising potential safety considerations due to these interactions.